| Entry |
|
| Name |
Tizaterkib (USAN/INN) |
| Formula |
C24H24F2N8O2
|
| Exact mass |
494.1990
|
| Mol weight |
494.50
|
| Structure |

|
| Remark |
|
| Efficacy |
Antineoplastic, Extracellular signal-regulated kinase inhibitor |
| Target |
|
| Pathway |
|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
CMGC group
ERK
D12921 Tizaterkib (USAN/INN)
|
| Other DBs |
|
| KCF data |
ATOM 36
1 N1y N 14.0700 -13.7200
2 C1y C 14.0700 -15.1200
3 C1x C 15.2824 -15.8200
4 N4y N 16.4949 -15.1200
5 C8y C 16.4949 -13.7200
6 C5x C 15.2824 -13.0200
7 C8x C 17.8264 -15.5526
8 C8y C 18.6493 -14.4200
9 N5x N 17.8264 -13.2874
10 O5x O 15.2824 -11.6202
11 C1b C 12.8576 -13.0200
12 C8y C 11.6621 -13.7104
13 C8x C 10.4747 -13.0249
14 C8y C 9.2623 -13.7250
15 C8y C 9.2624 -15.1250
16 C8x C 10.4497 -15.8104
17 C8x C 11.6621 -15.1104
18 X F 8.0355 -15.8336
19 X F 8.0310 -13.0140
20 C1b C 12.8576 -15.8200
21 O2a O 12.8576 -17.2200
22 C1a C 11.6621 -17.9104
23 C8y C 20.0200 -14.4200
24 N5x N 20.7200 -15.6324
25 C8y C 22.1200 -15.6324
26 N5x N 22.8200 -14.4200
27 C8x C 22.1200 -13.2076
28 C8y C 20.7200 -13.2076
29 C1a C 20.0296 -12.0121
30 N1b N 22.8104 -16.8279
31 C8y C 24.2197 -16.8280
32 N4y N 25.0296 -17.9422
33 N5x N 26.3395 -17.5163
34 C8x C 26.3393 -16.1389
35 C8x C 25.0292 -15.7134
36 C1a C 24.6071 -19.2447
BOND 40
1 1 2 1
2 3 2 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 2
11 6 10 2
12 1 11 1
13 11 12 1
14 12 13 2
15 13 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 12 17 1
20 15 18 1
21 14 19 1
22 2 20 1 #Down
23 20 21 1
24 21 22 1
25 8 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
32 28 29 1
33 25 30 1
34 30 31 1
35 31 32 1
36 32 33 1
37 33 34 2
38 34 35 1
39 31 35 2
40 32 36 1
|